Skip to main content
OpenTrials
Completed

NCT Number: NCT03487302

White Matter Hyperintensities Burden in Adult Patients With Cyanotic Congenital Heart Disease: a Pilot Study

The study aims at investigating the role of cyanotic congenital heart disease (cCHD) on brain aging. The investigators assume that due to congenital and acquired cardiovascular abnormalities, cCHD patients could show radiologic (and clinical) signs of precocious brain aging and eventual cognitive decline.

Completed

Looking for future studies?

Notify Me

Key information

About this study

White matter hyperintensities burden will be quantified through a semi-autamated software (ITK-SNAP)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • for the patient group, being an adult subject affected with cyanotic congenital heart disease, whether surgically corrected or not.
  • for the control group, being an healthy subject.

Exclusion criteria

  • any contraindication to magnetic resonance imaging;
  • any pathological condition and/or symptomp that could alter the white matter hyperintensities burden, among which:
  • inflammatory, infectious, demyelinating or dysmyelinating diseases of the CNS;
  • ischemic, haemorrhagic or traumatic brain events and eventual gliotic and malacic or lacunar sequelae;
  • genetic diseases (whether mendelian or mitochondrial) of the CNS;
  • cerebral amyloid angiopathy;
  • CADASIL;
  • cerebral arteriovenous malformations;
  • primary or metastatic brain neoplasms which cause neurological symptoms and/or brain parenchymal sequelae from surgical excision;
  • patent oval foramen;
  • being pregnant;
  • migraine with aura (Bashir, Lipton, Ashina, & Ashina, 2013).

Treatment and study plan

Brain MRI

Other

Acquisition of 3D T1-weighted, 3D FLAIR and GRE brain MRI scans

Neuropsychological test battery

Other
  • Mini Mental State Examination (MMSE), Measso et al. (1993);
  • Frontal Assessment Battery (FAB), Appollonio et al. (2005);
  • Symbol Digit Test, Amodio et al. (2002);
  • Digit Cancellation Test, Della Sala et al. (1992);
  • Trial Making Test (TMT A-B), Giovagnoli et al. (1996);
  • Weigl's Sorting Test, Laicona et al. (2000) and Inzaghi (2010);
  • Digit Span, Orsini et al (1987);
  • Corsi block-tapping test, Orsini et al. (1987);
  • Babcock story recall test, Carlesimo et al. (2002);
  • Phonemic verbal fluency in MDB, Caltagirone and Carlesimo (2010);
  • Semantic verbal fluency, Novelli (1986);
  • Imitating gestures, De Renzi et al. (1980);
  • Coloured Progressive Matrices (CPM47), Measso et al. (1993).

Primary outcomes

  1. White matter hyperintensities volume expressed in mm^3

    Time frame: 3 years

    Semi-automated quantification performed through ITK-SNAP

Sponsors and collaborators

Lead sponsor

IRCCS Policlinico S. Donato

Other

Registry information

Official study title

Assessment of White Matter Hyperintensities Burden in Adult Patients With Cyanotic Congenital Heart Disease: a Pilot Study

Important dates

Study start
2017
Primary completion
2021
Study completion
2021
First posted
Apr 4, 2018
Registry last updated
Sep 13, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.